TY - JOUR
T1 - Regulation of DNA damage response by trimeric G-proteins
AU - Abd El-Hafeez, Amer Ali
AU - Sun, Nina
AU - Chakraborty, Anirban
AU - Ear, Jason
AU - Roy, Suchismita
AU - Chamarthi, Pranavi
AU - Rajapakse, Navin
AU - Das, Soumita
AU - Luker, Kathryn E.
AU - Hazra, Tapas K.
AU - Luker, Gary D.
AU - Ghosh, Pradipta
N1 - Funding Information:
This work was supported by the National Institutes of Health Grants: CA238042 (to P.G and G.D.L), AI141630, CA100768, CA160911, and UG3TR002968 (to P.G.), U01CA210152, R01CA238023, R33CA225549 and R37CA222563 (GDL), HL145477 (to T.K.H.), R50CA221807 (to K.E.L) and DK107585 (S.D). T.K.H was also supported by NS073976 and W81XWH-18-1-0743. A.A.A was supported by an NIH-funded Cancer Therapeutics Training Program (CT2, T32 CA121938). J.E was supported by an NCI/NIH-funded Cancer Biology, Informatics & Omics (CBIO) Training Program (T32 CA067754) and a Postdoctoral Fellowship from the American Cancer Society (PF-18-101-01- CSM). S.R was supported, in part, by the NIH grants (AI118985 and GM117424). A. A. A. and P.G designed, executed, and analyzed most of the experiments in this work. N.S. carried out all work related to the generation of constructs used in this work. N.S, P.C. and N.R conducted the protein chemistry and biochemical analyses of the protein-protein interactions. A.C. and A.A.A. designed, executed, and analyzed the DNA mutation load assays in consultation with S.D and supervised by T.K.H. J.E designed, executed, and analyzed the BioID studies. S.R. carried out the structural modeling and analyses with supervision from P.G. K.E.L and G.D.L designed, executed, and analyzed the 53BP1 reporter studies in live cells. A. A. A. A.C and S.R wrote methods. A.A.A and P.G conceived the project, wrote and edited the article. Authors declare no competing interests.
Funding Information:
This work was supported by the National Institutes of Health Grants: CA238042 (to P.G and G.D.L), AI141630 , CA100768 , CA160911 , and UG3TR002968 (to P.G.), U01CA210152 , R01CA238023 , R33CA225549 and R37CA222563 (GDL), HL145477 (to T.K.H.), R50CA221807 (to K.E.L) and DK107585 (S.D). T.K.H was also supported by NS073976 and W81XWH-18-1-0743 . A.A.A was supported by an NIH-funded Cancer Therapeutics Training Program (CT2, T32 CA121938 ). J.E was supported by an NCI /NIH-funded Cancer Biology, Informatics & Omics (CBIO) Training Program ( T32 CA067754 ) and a Postdoctoral Fellowship from the American Cancer Society ( PF-18-101-01- CSM ). S.R was supported, in part, by the NIH grants ( AI118985 and GM117424 ).
Publisher Copyright:
© 2023 The Author(s)
PY - 2023/2/17
Y1 - 2023/2/17
N2 - Upon sensing DNA double-strand breaks (DSBs), eukaryotic cells either die or repair DSBs via one of the two competing pathways, i.e., non-homologous end-joining (NHEJ) or homologous recombination (HR). We show that cell fate after DSBs hinges on GIV/Girdin, a guanine nucleotide-exchange modulator of heterotrimeric Giα•βγ protein. GIV suppresses HR by binding and sequestering BRCA1, a key coordinator of multiple steps within the HR pathway, away from DSBs; it does so using a C-terminal motif that binds BRCA1's BRCT-modules via both phospho-dependent and -independent mechanisms. Using another non-overlapping C-terminal motif GIV binds and activates Gi and enhances the “free” Gβγ→PI-3-kinase→Akt pathway, which promotes survival and is known to suppress HR, favor NHEJ. Absence of GIV, or loss of either of its C-terminal motifs enhanced cell death upon genotoxic stress. Because GIV selectively binds other BRCT-containing proteins suggests that G-proteins may fine-tune sensing, repair, and survival after diverse types of DNA damage.
AB - Upon sensing DNA double-strand breaks (DSBs), eukaryotic cells either die or repair DSBs via one of the two competing pathways, i.e., non-homologous end-joining (NHEJ) or homologous recombination (HR). We show that cell fate after DSBs hinges on GIV/Girdin, a guanine nucleotide-exchange modulator of heterotrimeric Giα•βγ protein. GIV suppresses HR by binding and sequestering BRCA1, a key coordinator of multiple steps within the HR pathway, away from DSBs; it does so using a C-terminal motif that binds BRCA1's BRCT-modules via both phospho-dependent and -independent mechanisms. Using another non-overlapping C-terminal motif GIV binds and activates Gi and enhances the “free” Gβγ→PI-3-kinase→Akt pathway, which promotes survival and is known to suppress HR, favor NHEJ. Absence of GIV, or loss of either of its C-terminal motifs enhanced cell death upon genotoxic stress. Because GIV selectively binds other BRCT-containing proteins suggests that G-proteins may fine-tune sensing, repair, and survival after diverse types of DNA damage.
KW - Biological sciences
KW - Cell biology
KW - Molecular biology
UR - http://www.scopus.com/inward/record.url?scp=85147202153&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147202153&partnerID=8YFLogxK
U2 - 10.1016/j.isci.2023.105973
DO - 10.1016/j.isci.2023.105973
M3 - Article
AN - SCOPUS:85147202153
SN - 2589-0042
VL - 26
JO - iScience
JF - iScience
IS - 2
M1 - 105973
ER -